A map of molecular drug targets and therapeutics for the US FDA-approved drugs: The impact of expedited regulatory pathways and first-in-class drug approvals on drug innovation
用户Tj3F2ktlQedo
1个月前
82
10
已完结
1. 系统已在2026-08-11 23:18:19对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.pharmthera.2025.108945
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0163725825001573
其他信息:
出版社: Elsevier BV
作者: Pitchai Balakumar; N.V.L. Sirisha Mulukuri; Gowraganahalli Jagadeesh
